“…The analyses included a set of partial sequences of two nuclear genes: recombination activating 2 (RAG2) and myosin heavy chain 6 (MYH6); and partial sequences of three mitochondrial genes: 16S ribosomal RNA (16S), cytochrome c oxidase subunit I (COI) and NADH dehydrogenase subunit 4 (ND4). Amplification of the target DNA fragments was made through the polymerase chain reaction (PCR) method, using the following primers: MHRAG2‐F1 and MHRAG2‐R1 (Hardman & Page, ), RAG2 TRICHO F (5′‐GACAGYCGAGGATGCAATCGGAA‐3′) and RAG2 TRICHO R (5′‐CTGTCCTSCATYTCATGGGGTTCACG‐3′), herein described; myh6_F459 and myh6_R1322 (Li, Ortí, Zhang, & Lu, ), MYH6 TRICHO F (5′‐ACK GAC AGA GAG AAC CAG TC‐3′) and MYH6 TRICHO R (5′‐ACK GAC AGA GAG AAC CAG TC‐3′), herein described; 16SarL and 16SbrH (Palumbi, Martin, Romano, Stice, & Grabowski, ); L5698‐ASN and H7271‐COI (Villa‐Verde et al, ), FISHF1 and FISHR1 (Ward, Zemlak, Innes, Last, & Hebert, ); ND4 H3 L11935 and H12857 (Palumbi et al, ). Double‐stranded PCR amplifications were performed in 60 μl reactions with reagents at the following concentrations: 5 × GreenGoTaq Reaction Buffer (Promega), 3.2 mm MgCl 2 , 1 μm of each primer, 75 ng of total genomic DNA, 0.2 mm of each dNTP and 1 U of standard Taq polymerase or Promega GoTaq Hot Start polymerase.…”